Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$27.91
+0.22%
Mkt Cap $20.96B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
Implied Upside
+12.9%
Consensus $31.50 vs current $27.91
NASDAQ·Healthcare·Biotechnology
$27.91
+0.22%
Mkt Cap $20.96B
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$31.50
Range $30.00 – $34.00
+12.9%
Consensus $31.50 vs current $27.91